Ibáñez-Molero, Sofía
Veldman, Johanna
Simon Nieto, Juan
Traets, Joleen J. H.
George, Austin https://orcid.org/0009-0006-4786-2988
Hoefakker, Kelly
Karomi, Anita
Harkes, Rolf https://orcid.org/0000-0001-6592-654X
van den Broek, Bram https://orcid.org/0000-0003-1037-907X
Pack, Su Min https://orcid.org/0000-0002-8480-238X
Tas, Liselotte
Visser, Nils L.
van Hal-van Veen, Susan E.
Alóndiga-Mérida, Paula
Alkemade, Maartje
Seignette, Iris M. https://orcid.org/0009-0007-7757-698X
Tissier, Renaud
Nieuwland, Marja
van Baalen, Martijn
Poźniak, Joanna
Mul, Erik
Tol, Simon
Stenqvist, Sofia
Nilsson, Lisa M.
Nilsson, Jonas A. https://orcid.org/0000-0003-0346-6837
Haanen, John B. A. G. https://orcid.org/0000-0001-5884-7704
van Houdt, Winan J.
Peeper, Daniel S. https://orcid.org/0000-0003-1293-3177
Article History
Received: 2 August 2023
Accepted: 14 October 2025
First Online: 19 November 2025
Competing interests
: S.I.-M., J.V. and D.S.P. are named as inventors on patent P097110NL based on this work. J.B.A.G.H. has provided consultation, attended advisory boards and/or provided lectures for BMS, CureVac, GSK, Imcyse, Iovance Bio, Instil Bio, Immunocore, Ipsen, Merck Serono, MSD, Molecular Partners, Novartis, Pfizer, Roche/Genentech, Sanofi, Scenic and Third Rock Ventures; has participated in the scientific advisory board of Achilles Tx, BioNTech US, Instil Bio, PokeAcell, T-Knife, Scenic and Neogene Therapeutics; and through this the NKI has received grant support from Amgen, Asher Bio, BioNTech, BMS, MSD, Novartis, Sastra Cell Therapy, has stock options in Neogene Tx. D.S.P. is co-founder, shareholder and advisor of Flindr Therapeutics, which is unrelated to this study. J.V. is funded by a Veni-fellowship from the Dutch Research Council (NWO): 09150162210069. J.A.N. is funded by the Swedish Cancer Society, Vetenskapsrådet, the Erling-Persson and Sjöberg Foundations. D.S.P. is funded by the Oncode Institute, the Dutch Cancer Society KWF and by an ERC Advanced grant 101054465—ReverT. The other authors declare no competing interests.